ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,400Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 106

$568K Total Retail Price of All Prescriptions

Rank: 21 out of 106

315 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

16% of this provider’s 315 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 8,635 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 59%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $178 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
FUROSEMIDE 437 395 1 7
SIMVASTATIN 320 251 2 14
LEVOTHYROXINE SODIUM 267 255 3 17
OMEPRAZOLE 263 249 4 10
LISINOPRIL 233 189 5 13
HYDROCODONE-ACETAMINOPHEN 223 207 S3 6 9
DONEPEZIL HCL 220 220 7 47
NAMENDA 196 196 8 58
METOPROLOL TARTRATE 192 159 9 16
SERTRALINE HCL 184 164 10 35
WARFARIN SODIUM 180 141 11 21
AMLODIPINE BESYLATE 174 161 12 19
KLOR-CON M20 151 141 13 64
GABAPENTIN 148 118 14 27
SPIRIVA 144 89 15 1
IPRATROPIUM-ALBUTEROL 140 126 16 103
MIRTAZAPINE 139 118 17 60
LEVOFLOXACIN 131 97 18 20
CITALOPRAM HBR 128 109 19 31
OXYCODONE-ACETAMINOPHEN 121 91 S2 20 96
NITROFURANTOIN MONO-MACRO 120 107 21 134
BACLOFEN 118 64 22 135
ALENDRONATE SODIUM 115 115 23 42
NOVOLOG 107 99 24 140
HYDROCHLOROTHIAZIDE 104 90 25 25
TAMSULOSIN HCL 101 101 26 52
TRAZODONE HCL 101 76 26 51
CARBIDOPA-LEVODOPA 98 85 28 87
FAMOTIDINE 92 74 29 90
LANTUS 89 66 30 74
SYMBICORT 88 29 31 4
DIVALPROEX SODIUM 87 66 32 94
RISPERIDONE 87 87 32 71
QUETIAPINE FUMARATE 86 78 34 91
METFORMIN HCL 84 70 35 23
POTASSIUM CHLORIDE 82 78 36 24
FENTANYL 80 42 S2 37 111
COMBIVENT 80 38 37 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 72 39 29
PANTOPRAZOLE SODIUM 78 56 39 37
ESCITALOPRAM OXALATE 77 65 41 68
PROMETHAZINE HCL 73 56 R 42 82
CIPROFLOXACIN HCL 68 60 43 48
LEVETIRACETAM 67 57 44 137
ALLOPURINOL 67 55 44 62
FLUTICASONE PROPIONATE 67 60 44 18
BUDESONIDE 67 59 44 166
ZOLPIDEM TARTRATE 64 50 48 22
SINGULAIR 62 46 49 11
METOCLOPRAMIDE HCL 57 31 50 56
LOSARTAN POTASSIUM 55 51 51 34
GENTAMICIN SULFATE 55 54 51 181
ATORVASTATIN CALCIUM 54 39 53 30
CYMBALTA 54 44 53 89
OXYBUTYNIN CHLORIDE ER 53 53 55 183
PHENYTOIN SODIUM EXTENDED 52 33 56 114
LATANOPROST 50 49 57 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.